2 results
Approved WMOCompleted
The objective of this project is to assess the applicability of [11C]GMOM for in vivo imaging of the NMDA receptor.
Approved WMOCompleted
Primary objective:To demonstrate the efficacy of Rifaximin -EIR 400 mg Tablet (800mg /BID, total daily dose 1600 mg) versus placebo in the prevention of endoscopic Crohn*s disease recurrence following ileocolonic resection